Insider · CIK 0001299153
Ronald Asbury Andrews
director
Files at PRPO (Precipio, Inc.), CNSY (PLUS THERAPEUTICS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CNSY PLUS THERAPEUTICS, INC. | MOption exercise Common Stock | +921 | $0.00 | $0 | 1,843 | 11 d ago |
| Oct 1, 2026 | CNSY PLUS THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -921 | $0.00 | $0 | 1,843 | 11 d ago |
| Oct 15, 2025 | PRPO Precipio, Inc. | AGrant or award Common Stock | +568 | $17.58 | $9,985 | 15,708 | Oct 16, 2025 |
| Jul 16, 2025 | PRPO Precipio, Inc. | AGrant or award Common Stock | +676 | $14.78 | $9,991 | 15,228 | Jul 18, 2025 |
| Apr 15, 2025 | PRPO Precipio, Inc. | AGrant or award Common Stock | +1,785 | $5.60 | $9,996 | 14,552 | Apr 17, 2025 |
| Jan 15, 2025 | PRPO Precipio, Inc. | AGrant or award Common Stock | +1,639 | $6.10 | $9,998 | 12,767 | Jan 16, 2025 |
| Jan 14, 2025 | PRPO Precipio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Jan 16, 2025 |
| Oct 15, 2024 | PRPO Precipio, Inc. | AGrant or award Common Stock | +1,510 | $6.62 | $9,996 | 11,128 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.